Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Multi-billion $ markets to be disrupted by LXG

<< Previous

Bullboard Posts

Next >>

Comment by ragb7002on Aug 09, 2020 1:42pm

80 Views

Post# 31384678

RE:Multi-billion $ markets to be disrupted by LXG

If so wonderful,why haven't the boneheads at FDA given approvals already. Prototype was ready Nov 30th/17. What's the answer. Micro Canadian company. Don't tell me they are American because they have a facility in Beverly!!!!!

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features